Evidence map›Paper›PMID 36551097›Full record

ArticleBiosensors2022

Gold Nanoparticles-MWCNT Based Aptasensor for Early Diagnosis of Prostate Cancer.

Aseel Alnaimi, Ammar Al-Hamry, Yahia Makableh, Anurag Adiraju, Olfa Kanoun

Abstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Advances in Prostate Cancer Biomarkers and Probes.Cyborg and bionic systems (Washington, D.C.) · 2024
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aseel AlnaimiBiomedical Engineering Department, Jordan University of Science and Technology, Irbid 22110, Jordan.ORCID 0000-0002-8536-4270
Ammar Al-HamryProfessorship Measurement and Sensor Technology, Chemnitz University of Technology, 09111 Chemnitz, Germany.ORCID 0000-0003-0952-3134
Yahia MakablehInstitute of Nanotechnology, Jordan University of Science and Technology, Irbid 22110, Jordan.ORCID 0000-0002-1500-6144
Anurag AdirajuProfessorship Measurement and Sensor Technology, Chemnitz University of Technology, 09111 Chemnitz, Germany.
Olfa KanounProfessorship Measurement and Sensor Technology, Chemnitz University of Technology, 09111 Chemnitz, Germany.ORCID 0000-0002-7166-1266

Funding

German Academic Exchange Service KA 1663/12-1
6 · The paper itself

Abstract

Prostate cancer is one of the most frequently diagnosed male malignancies and can be detected by prostate-specific antigen (PSA) as a biomarker. To detect PSA, several studies have proposed using antibodies, which are not economical and require a long reaction time. In this study, we propose to use self-assembled thiolated single-strand DNA on electrodes functionalized by multi-walled carbon nanotubes (MWCNT) modified with gold nanoparticles (AuNPs) to realize a low-cost label-free electrochemical biosensor. In this regard, the PSA aptamer was immobilized via electrostatic adsorption on the surface of a screen-printed MWCNT/AuNPs electrode. The immobilization process was enhanced due to the presence of Au nanoparticles on the surface of the electrode. Surface characterization of the electrode at different stages of modification was performed by electrochemical impedance spectroscopy (EIS), atomic force microscopy (AFM) and Fourier transform infrared spectroscopy (FTIR) and contact angle for surface tension properties. The results showed an increase in surface roughness due to the absorbance of the aptamer on the electrode surfaces. The developed sensor has an extended linear range of 1-100 ng/mL, and a very low limit of detection down to 1 pg/mL. In addition, the reaction has a binding time of only five minutes on the developed electrodes. Investigations of the biosensor selectivity against several substances revealed an efficient selectivity for PSA detection. With this approach, low-cost biosensors with high sensitivity can be realized which have a wide linearity range and a low limit of detection, which are necessary for the early detection of prostate cancer.

Indexed as

Aptamers, NucleotideBiosensing TechniquesMetal NanoparticlesNanotubes, CarbonProstatic NeoplasmsEarly Detection of CancerElectrochemical TechniquesElectrodesGoldHumansLimit of DetectionMaleProstate-Specific AntigenAptamers, NucleotideGoldNanotubes, CarbonProstate-Specific Antigenaptasensorcarbon nanotubesgold nanoparticlesprostate cancerprostate-specific antigen

Identifiers

PMID36551097
PMCPMC9776393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.